Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)


Wednesday 04 November, 2020

Accrol Group Hldgs

Posting of Circular

RNS Number : 2980E
Accrol Group Holdings PLC
04 November 2020

4 November 2020



("Accrol" or the "Company")

Posting of Circular


Accrol Group Holdings plc (AIM:ACRL) is pleased to announce that, further to the announcement made by the Company on 3 November 2020 concerning the "Confirmation of Successful Placing", the Company has today posted the Circular containing further details of the Placing and outlining the terms of  the Open Offer for up to a further c.£4.1 million and convening the General Meeting, together with an Application Form for Qualifying Non-CREST Shareholders.


In light of Government guidance in relation to the COVID-19 pandemic, Shareholders are advised that the General Meeting will be held as a closed meeting with limited attendees to ensure that the meeting is quorate. In lieu of attending the General Meeting, all other Shareholders are requested to appoint a proxy with their voting instructions. Details of how to do so are included in the Circular.


A copy of the Circular is available on the Company's website


Capitalised terms used but not defined in this announcement have the same meanings as set out in the Company's announcement of its proposed fundraising dated 2 November 2020.


For further information, please contact:




Accrol Group Holdings plc


Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush

Edward Thomas

Belvedere Communications Limited


Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

Llew Angus

Tel:  +44 (0) 7407 023 147

[email protected]


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t